Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes
about
Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiationThe effect of Lipoxin A4 on the interaction between macrophage and osteoblast: possible role in the treatment of aseptic loosening.Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery.Megalin-mediated specific uptake of chitosan/siRNA nanoparticles in mouse kidney proximal tubule epithelial cells enables AQP1 gene silencing.Different roles of 12/15-lipoxygenase in diabetic large and small fiber peripheral and autonomic neuropathies.Poly(ADP-ribose) polymerase-1 (PARP-1) gene deficiency alleviates diabetic kidney disease.Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat modelRole of 12/15-lipoxygenase in nitrosative stress and peripheral prediabetic and diabetic neuropathiesRepression of let-7 by transforming growth factor-β1-induced Lin28 upregulates collagen expression in glomerular mesangial cells under diabetic conditions.siRNA delivery to the glomerular mesangium using polycationic cyclodextrin nanoparticles containing siRNAPrediabetic nephropathy as an early consequence of the high-calorie/high-fat diet: relation to oxidative stress.Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy.RNA interference-mediated targeting of human cytomegalovirus immediate-early or early gene products inhibits viral replication with differential effects on cellular functions.Mice lacking macrophage 12/15-lipoxygenase are resistant to experimental hypertension.Epigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic NephropathyInvolvement of p300/CBP and epigenetic histone acetylation in TGF-β1-mediated gene transcription in mesangial cellsThe efficacy of nuclease-resistant Chol-siRNA in primary breast tumors following complexation with PLL-PEG(5K)12-Lipoxygenase Inhibition on Microalbuminuria in Type-1 and Type-2 Diabetes Is Associated with Changes of Glomerular Angiotensin II Type 1 Receptor Related to Insulin Resistance.MicroRNAs and their role in progressive kidney diseases.Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy.Lipidic systems for in vivo siRNA delivery.New short interfering RNA-based therapies for glomerulonephritis.Towards microRNA-based therapeutics for diabetic nephropathy.Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db/db mice.Inhibition of 12/15-Lipoxygenase Reduces Renal Inflammation and Injury in Streptozotocin-Induced Diabetic Mice.Metformin attenuates angiotensin II-induced TGFβ1 expression by targeting hepatocyte nuclear factor-4-α.
P2860
Q30433016-D3749B7C-CEF0-4A84-BF12-415A6A7E6A9FQ33458930-F5C9102E-3949-4F94-92F2-FDCC8526CDCCQ33830955-13A90F15-B3E3-4D85-8424-4B94CD778FC3Q34080235-8A95CDE8-0AA0-443F-BBF1-4B415C5C1A49Q34086993-BD9A59F6-55A7-4422-B3EC-232ABB024E41Q34441033-D4CBB5C6-59C7-49ED-B334-F6A9C8DC446FQ34653233-19761472-E8EF-4E5D-AB28-4F89EAC481CDQ34667363-9ABD593A-831B-42EB-9AA5-1A850B6ED561Q34726882-00FDD08D-069F-4301-8801-56DCB7DD3B5EQ35224125-386CE518-4309-4AAE-B349-61BE22835411Q35762675-173814B8-95F4-406F-8FEE-C60B5AA30430Q35804221-2A8FCF69-6125-4575-82CC-0F1EE7DFAC65Q35943427-287062B9-5865-4318-9D93-C27633AEEBCFQ36042687-35F7DB65-C460-4C65-B4EC-E123FCE8819BQ36656799-EC059D41-9AF0-4807-BF70-A82DB11A7BD7Q36699878-A400A28E-E538-4B28-9077-E00C71739581Q36830564-0F148215-AD99-431B-8C2D-B60DC894064CQ36939224-4B81495E-FC66-4EC8-9486-4CCB6CBAA09BQ37258870-DC865619-EA1D-45E5-9855-992DE3A23DFBQ37482925-40BFCCCA-CDC9-43FC-B07A-565F78C45045Q37598096-28A185BA-F0AB-45BA-8B1D-AA479B7E2F7CQ37879444-0E52EDFB-068B-4A9A-96A1-D131B00FA896Q39523597-8BB9286B-DCD0-4373-90D4-AE065B12A711Q41939992-6E6A7D74-6A17-4A8B-B6E9-B483122EA94CQ42228384-2053E30F-9327-4871-8327-A7165B9DB3D0Q51125944-A9C3C352-A86C-4365-9059-AFB92EDCAEF4
P2860
Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Effects of cholesterol-tagged ...... mouse model of type 1 diabetes
@en
type
label
Effects of cholesterol-tagged ...... mouse model of type 1 diabetes
@en
prefLabel
Effects of cholesterol-tagged ...... mouse model of type 1 diabetes
@en
P2093
P2860
P1476
Effects of cholesterol-tagged ...... mouse model of type 1 diabetes
@en
P2093
Linda Lanting
Mahesh Jonnalagadda
Piotr Swiderski
Rama Natarajan
Shu-Lian Li
Sumanth Putta
Zhong-Gao Xu
P2860
P304
P356
10.1152/AJPRENAL.90268.2008
P50
P577
2008-06-18T00:00:00Z